Crispr Therapeutics shares tumble after significant earnings miss
Gabelli Equity Trust Closed Fund stock has reached a new 52-week high, hitting 5.93 USD. This milestone reflects a significant performance over the past year, with the stock delivering an impressive 24.43% total return. The fund currently offers a substantial 10.15% dividend yield, supported by a 39-year track record of consistent dividend payments. The investment trust, known for its diversified equity portfolio, has demonstrated resilience and growth potential in the current market environment. With a market capitalization of $1.82 billion and a P/E ratio of 9.68, investors have shown increased confidence in the fund, driving the stock to this new high. InvestingPro analysis reveals several additional positive indicators, with 6 more exclusive ProTips available to subscribers, offering deeper insights into the fund’s potential.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.